Tumor necrosis factor inhibitor drugs industry is projected to witness a CAGR of 2.2% during the period 2024-2032. This growth can be attributed to advancements in biotechnology and drug ...

Make sure you are consulting regularly with a rheumatologist, making healthy choices, and following the treatment plan ... cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ ...

These joints open, close, and tighten the vocal cords during speech and breathing. Cricoarytenoid arthritis can usually be managed by treating rheumatoid arthritis or another underlying condition ...

A collaboration between Weill Cornell Medicine (NY, USA) and the Hospital for Special Surgery (NY, USA) has developed a machine-learning tool that can distinguish between three subtypes of rheumatoid ...

She said we’d need to explore other options for more sustainable treatment. That’s when I was introduced to disease-modifying antirheumatic drugs (DMARDs). We started with methotrexate, which is ...

Joint pain may result from arthritis, injuries, inflammation, aging, infections or lifestyle factors. The article outlines ...

Scientists at MedStar Georgetown University Hospital have recently uncovered a promising new way to treat knee pain, ...

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism.

Objectives Most studies on difficult-to-treat rheumatoid arthritis (D2T RA) have focused on established RA. Here, we analyse whether disease activity in the early stages of RA could influence ...

In this way, the 2010 ACR/EULAR Rheumatoid Arthritis classification criteria have shown to be more sensitive than the ACR 1987 criteria and include better patients with early RA. Other important point ...

Despite these issues, Malani and colleagues say their study puts an important focus on diet in the ... Glucocorticoid treatment for rheumatoid arthritis is associated with an increased risk ...

Methods Patients with RA (symptom duration <2 years) were included from two randomised trials: BehandelStrategieën (BeSt), n=508 and Induction therapy with Methotrexate and Prednisone in Rheumatoid Or ...